Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › NY › Rochester › NPI 1609937796
Supplier

University of Rochester

University of Rochester was paid $87K by Medicaid between Jan 2018 and Dec 2024, across 11 billing codes. Its largest line is A4239, Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service — 32% of everything it billed.

33Billing provider infoUNIVERSITY OF ROCHESTER
ROCHESTER, NY 14642
33aNPI1609937796assigned 12/12/2006
33bProvider typePharmacy
28Total paid$87K
24GClaims33,259
24DCodes billed11
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Pharmacy providers in New York

Rank by total paid#29 of 126
Median peer was paid$2K
This provider vs. median37×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official SMITH, JASON controls 16+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$5.0K$10K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
20183,524$8K
20194,209$5K
20204,901$11K
20214,903$8K
20225,420$9K
20235,225$16K
2024incomplete5,077$29K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
A4239 Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service 32% 674 662 $27K
J7507 Tacrolimus, immediate release, oral, 1 mg 22% 5,275 4,765 $19K
J7517 Mycophenolate mofetil, oral, 250 mg 15% 4,482 4,212 $13K
Q0511 Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period 9.4% 6,046 5,657 $8K
A4253 Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips 7.0% 1,224 1,206 $6K
Q0512 Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period 6.7% 10,274 5,564 $6K
J7503 Tacrolimus, extended release, (envarsus xr), oral, 0.25 mg 5.3% 516 440 $5K
A4215 Needle, sterile, any size, each <1% 27 27 $847.21
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 4,372 4,111 $614.70
A4259 Lancets, per box of 100 <1% 355 350 $548.19
K0553 Supply allowance for therapeutic continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service <1% 14 14 $507.77

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialSMITH, JASON (ASSOC DIRECTOR OF PHARMACY)
Same official

Other billing entities under SMITH, JASON

Full network →

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.